1-3 of 3
risk of ovarian cancer algorithm
Close
Sort by
Journal Articles

Impact of Velaglucerase Alfa in the Inflammatory Status of Type 1 Gaucher Disease Patients after One Year on Therapy. A Prospective Multicentre Study

Marcio Andrade-Campos, MD, Javier Gervas, PhD, Inmaculada García-Jiménez, MD, Olga Salamero, Pedro Martinez-Odriozola, MD, Jose Angel Mendez, MD, Fernando Garcia-Bragado, MD, Cristina Fernandez-Canal, MD, Luis Ignacio Sancho-Val, PhD, Horacio Cano, MD, Jordi Perez-Lopez, MD, Jesus Maria Hernandez-Rivas, PhD, Juan Francisco Lorenzo, MD, Miguel Lopez-Dupla, MD, Virginia Callao, PhD, Pilar Giraldo, PhD
Journal: Blood
Blood (2015) 126 (23): 4606.
https://doi.org/10.1182/blood.V126.23.4606.4606
Published: 2015
Journal Articles

A Phase 1 Study of the BET-Bromodomain Inhibitor OTX015 in Patients with Advanced Acute Leukemia

Hervé Dombret, MD PhD, Claude Preudhomme, MD PhD, Céline Berthon, MD, Emmanuel Raffoux, MD, Xavier Thomas, MD PhD, Norbert Vey, MDPhD, Carlos Gomez-Roca, MD, Mark Ethell, MD, Karen Yee, MD, Fabrice Bourdel, MSc, Patrice Herait, MD PhD, Mauricette Michallet, MD PhD, Christian Recher, MDPhD, Christophe Roumier, Bruno Quesnel, MD
Journal: Blood
Blood (2014) 124 (21): 117.
https://doi.org/10.1182/blood.V124.21.117.117
Published: 2014
Journal Articles

Bone Loss Study in Type 1 Gaucher Disease by Two Different Technologies

Mercedes Roca, Paz Latre, Pilar Alfonso, Pilar Irun, Ignacio Civeira, Erardo Meriño, Miguel Pocovi, Pilar Giraldo, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 4650.
https://doi.org/10.1182/blood.V112.11.4650.4650
Published: 2008